SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000918066-04-000033
Filing Date
2004-02-20
Accepted
2004-02-20 11:29:10
Documents
1
Period of Report
2004-02-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT c0001236486d20040220f4f.html 4  
1 PRIMARY DOCUMENT c0001236486d20040220f4f.xml 4 5998
  Complete submission text file 0000918066-04-000033.txt   7641
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Issuer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GUILFORD PHARMACEUTICALS INC 661 TIBUTARY STREET BALTIMORE MD 21224
Business Address
KELLY MICHAEL /NMN/ (Reporting) CIK: 0001236486 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23736 | Film No.: 04618222